BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12521589)

  • 1. Inflammation and anti-inflammatory therapy in chronic prostatitis.
    A Pontari M
    Urology; 2002 Dec; 60(6 Suppl):29-33; discussion 33-4. PubMed ID: 12521589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study.
    Schaeffer AJ; Knauss JS; Landis JR; Propert KJ; Alexander RB; Litwin MS; Nickel JC; O'Leary MP; Nadler RB; Pontari MA; Shoskes DA; Zeitlin SI; Fowler JE; Mazurick CA; Kusek JW; Nyberg LM;
    J Urol; 2002 Sep; 168(3):1048-53. PubMed ID: 12187220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Vicari E; Salemi M; Sidoti G; Malaguarnera M; Castiglione R
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29099760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
    Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
    Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?
    Nickel JC; Shoskes D; Wang Y; Alexander RB; Fowler JE; Zeitlin S; O'Leary MP; Pontari MA; Schaeffer AJ; Landis JR; Nyberg L; Kusek JW; Propert KJ
    J Urol; 2006 Jul; 176(1):119-24. PubMed ID: 16753385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls.
    Nickel JC; Alexander RB; Schaeffer AJ; Landis JR; Knauss JS; Propert KJ;
    J Urol; 2003 Sep; 170(3):818-22. PubMed ID: 12913707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.
    Pontari MA
    Drugs Aging; 2003; 20(15):1111-25. PubMed ID: 14651434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
    BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NIH Consensus concept of chronic prostatitis/chronic pelvic pain syndrome compared with traditional concepts of nonbacterial prostatitis and prostatodynia.
    Krieger JN; Ross SO; Deutsch L; Riley DE
    Curr Urol Rep; 2002 Aug; 3(4):301-6. PubMed ID: 12149161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of symptoms in men with chronic pelvic pain].
    Hochreiter WW; Hruz P; Danuser H; Weidner W; Studer UE
    Urologe A; 2003 Jan; 42(1):38-40. PubMed ID: 12574882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS; Parikh A
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
    Wang J; Yan D; Liang K; Xu Z
    Int Urol Nephrol; 2016 Jan; 48(1):13-8. PubMed ID: 26577998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.
    Nickel JC; Downey J; Johnston B; Clark J;
    J Urol; 2001 May; 165(5):1539-44. PubMed ID: 11342913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
    Abdel-Meguid TA; Mosli HA; Farsi H; Alsayyad A; Tayib A; Sait M; Abdelsalam A
    Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial.
    Nickel JC; Johnston B; Downey J; Barkin J; Pommerville P; Gregoire M; Ramsey E
    Urology; 2000 Sep; 56(3):413-7. PubMed ID: 10962305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the cytokines in genital secretions of patients with chronic prostatitis.
    Paulis G; Conti E; Voliani S; Bertozzi MA; Sarteschi ML; Menchini Fabris F
    Arch Ital Urol Androl; 2003 Dec; 75(4):179-86. PubMed ID: 15005490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
    BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.